Research units - Stem Cell Regulation

Stem Cell Regulation

Billions of blood cells are produced in our body each day, due to highly controlled regulation of self-renewal and differentiation processes of blood stem cells. Blood cell production predominantly occurs in the bone marrow and the non-blood cell types present in the bone marrow (collectively called the bone marrow microenvironment) are important in helping to control blood cell production from stem cells. Incomplete production or function of the different blood cell types or problems arising in the function or composition of the non-blood cells that regulate blood cell production can lead to blood cell diseases such as cancers.

Research Overview

The Stem Cell Regulation Group is interested in learning how stem cells, in particular blood cell-forming stem cells and bone-forming stem cells, are regulated to either increase in number (by a process termed self-renewal) or produce more blood cells (a process termed differentiation). We are also interested in learning how cells of the bone marrow microenvironment (where blood stem cells normally reside) interact with blood stem cells to regulate both self-renewal of blood stem cells and blood cell production from blood stem cells. In a separate theme, we have also recently established the most faithful small animal model of osteosarcoma, a bone cancer that occurs predominantly in teenagers, and are using this model to determine processes involved in the initiation, progression and metastasis of this cancer.

Research Themes

The regulation of blood stem cell self-renewal and differentiation

The roles of the bone marrow microenvironment in regulating blood cell production

Epigenetic regulation of stem cells

Modeling osteosarcoma (bone cancer)

Honours and PhD Projects

Identification of osteoblast lineage cells by FACS in normal and cancerous states

Impact of TNFalpha in the bone marrow microenvironment in normal and stressed situations

Targeting different HoxA1 isoforms for cancer therapeutics

Improving blood cell recovery after cytotoxic regimens

Staff

Staff image

A/Prof Louise Purton
Dr Carl Walkley
Dr Emma Baker
Ankita Gupte
Brian Liddicoat
Emma Baker
Jean Hendy
Dr Julie Quach
Megan Russell
Tanja Jovic
Alvin Ng
Hui Peng Lim
Chacko Joseph
Alanna Green

Publication Highlights

  1. Walkley CR, JM Shea, NA Sims, LE Purton & SH Orkin. Rb Regulates Interactions Between Hematopoietic Stem Cells and their Bone Marrow Microenvironment. Cell 2007; 129: 1081-1095. 
  2. Walkley CR*, G. Haines Olsen*, S Dworkin, SA Fabb, J Swann, GA McArthur, SV Westmoreland, P Chambon, DT Scadden & LE Purton. A Microenvironment-Induced Myeloproliferative Syndrome Caused by Retinoic Acid Receptor γ Deficiency. Cell 2007; 129: 1097-1110.
  3. North TE, W Goessling, CR Walkley, C Lengerke, KR Kopani, AM Lord, G Weber, T Venezia, IH Jang, T Grosser, GA FitzGerald, GQ Daley, SH Orkin & LI Zon. Prostaglandin E2 Regulates Vertebrate Haematopoietic Stem Cell Homeostasis. Nature 2007; 447: 1007-1011.
  4. Purton LE. Roles of retinoids and retinoic acid receptors in the regulation of hematopoietic stem cell self-renewal and differentiation. PPAR Research 2007 (doi:10.1155/2007/87934).
  5. Purton LE, Scadden DT. Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell 2007; 1:263-270.
  6. Wu JY*, Purton LE*, Rodda S, Chen M, Weinstein LS, McMahon AP, Scadden DT, Kronenberg HM. Osteoblastic regulation of B lymphopoiesis is mediated by Gsalpha-dependent signaling pathways. PNAS 2008; 105:16976-16981.
  7. Sankaran, VG, SH Orkin & CR Walkley. Rb Intrinsically Promotes Erythropoiesis by Coupling Cell Cycle Exit with Mitochondrial Biogenesis. Genes & Development 2008; 22(4): 463-475. 
  8. Walkley CR, R Qudsi, VG Sankaran, JA Perry, M Gostissa, SI Roth, SJ Rodda, E Snay, P Dunning, FH Fahey, FW Alt, AP McMahon & SH Orkin. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes & Development 2008; 22(12):1662-1676. 
  9. Hartner JC, CR Walkley, J Lu & SH Orkin. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nature Immunology 2009;10(1):109-115. 
  10. Askmyr M, Sims NA, Martin TJ, Purton LE. What is the true nature of the osteoblastic hematopoietic stem cell niche? (Invited Review) Trends in Endocrinology and Metabolism. 2009; 20:303-309.